Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Astellas Pharma Incorporated
sales of 1.37 trillion Japanese Yen [US$12.35 billion]
of which 57%
Otsuka Holdings Company Limited
(1.20 trillion Japanese Yen [US$10.76 billion]
Daiichi Sankyo Company Limited
(986.45 billion Japanese Yen [US$8.88 billion]
of which 94%
was prescription drugs).
Takeda Pharmaceutical Company Limited reported sales of ¥1.81 trillion (US$16.27 billion)
March of 2016.
a very small
increase of 1.7%
versus 2015, when the company's sales were ¥1.78 trillion.
Sales at Takeda Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 27%).
Sales of Healthcare saw an increase
that was more than double the company's growth rate: sales were up
8.9% in 2016, from
¥73.58 billion to ¥80.09 billion.
Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2016:
sales of Other fell 12.4% to ¥78.61 billion.